Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Labetalol hydrochloride 100 mg oral tablet |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 50 mg oral tablet |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 100mg/20mL injection (substance) |
Is a |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely labetalol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 100mg/20mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 50mg/10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide + labetalol hydrochloride 25mg/200mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 5mg/ml injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 5mg/ml injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 5mg/ml injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 50mg/10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Labetalol hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 100 mg oral tablet |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 300 mg oral tablet |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Labetalol hydrochloride 50 mg oral tablet |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has precise active ingredient |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely labetalol hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has precise active ingredient |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Labetalol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |